Genechron selected among the projects that will participate in the Bio In Italy roadshow
Bio In Italy Investment is a forum organized by Assobiotec and Intesa Sanpaolo Innovation Center. At its eleventh edition it is now a reference event for innovation in biotechnologies and life sciences in Italy and uses regional partners for the scouting of the best talents on the territory.
Three of the eight innovative projects were selected, including Genechron, as an innovative startup operating in the molecular biomarker sector for hepatotoxicity and epilepsy. All of them concluded the startup journey with Lazio Innova and were presented at the call of the Life Sciences and Circular Bio Economy sector last December.
The teams will participate at the bootcamp phase at the Intesa San Paolo Innovation Center in Turin, preparatory to the final with investors and Business Angels in April, at the Cariplo Factory in Milan.